RE:RE:RE:RE:RE:New CMO announced JJ, have to disagree somewhat. We need a deal of some sort. They have been producing monoclonal antibodies for years and talking about partnerships. Nothing to date that's what's missing. With the type of news over the last couple of years that NR yesterday wouldn't have moved the needle on the Nasdaq either. You can only communicate your science for so long before the investment community stops drinking the coolaid. Not making a deal says more!!! and if a deal comes we'll be fine on the markets were on. Interested investors know how to get there.